Clinical Trials Logo

Breast Cancer clinical trials

View clinical trials related to Breast Cancer.

Filter by:

NCT ID: NCT03619993 Completed - Breast Cancer Clinical Trials

Patient Preference for Pegfilgrastim (Neulasta®) Application Forms

CONVENIENCE
Start date: June 25, 2018
Phase: N/A
Study type: Interventional

The study aims to compare two application forms (pre-filled syringe and On-body injector) of the same active drug (pegfilgrastim) in adult patients under chemotherapy regarding patient preference and health economics. Chemotherapy will be supported with pegfilgrastim for four subsequent chemotherapy cycles using alternating application forms.

NCT ID: NCT03619967 Completed - Breast Cancer Clinical Trials

Sentinel Lymph Node Mapping With Near Infrared Fluorescent Markers

Start date: July 20, 2018
Phase: N/A
Study type: Interventional

Surgery is the primary curative option for patients with cancer, with the overall objective of complete resection of all cancerous tissue while avoiding damage to healthy tissue. In addition, sentinel lymph node (SLN) mapping and resection is an essential step in staging and managing the disease. Even with the latest advancements in imaging technology, incomplete tumor resection in patients with breast cancer is at an alarming rate of 20-25%, with recurrence rates of up to 27%. The clinical need for imaging instruments that provide real-time feedback in the operating room is unmet, largely due to the use of imaging systems based on contemporary technological advances in the semiconductor and optical fields, which have bulky and costly designs with suboptimal sensitivity and co-registration accuracy between multimodal images. To address these challenges, the investigators have introduced an innovative design comprising a bio-inspired multispectral sensor which can significantly improve image-guided surgery. The objective of this clinical study is to determine the feasibility of using a bio-inspired multispectral imaging system to detect sentinel lymph nodes and cancerous tissue during intraoperative procedures in patients with breast cancer.

NCT ID: NCT03619681 Completed - Breast Cancer Clinical Trials

Trial of KN026 in Patients With HER2-positive Advanced Malignant Breast Cancer and Gastric Cancer

Start date: September 17, 2018
Phase: Phase 1
Study type: Interventional

This is a first-in-human (FIH), open-label, phase 1 dose-escalation study of KN026 in subjects with HER2 positive advanced breast and Gastric Cancer. The standard "3 + 3" design was used for dose escalation. There are 5 proposed dose levels which are 5, 10, 15, 20 and 30 mg/kg, but dosing interval may be adjusted during the study (such as QW, OR Q2W, OR Q3W) based on emerging data from this trial and/or from phase 1 trial of KN026 in other country. Dose escalation will continue until the maximum tolerated dose (MTD) is reached or if MTD is not found, dose escalation will continue until the MAD of 20 mg / kg is reached. Dose expansion will carried out in 20 mg/kg Q2W and 30 mg/kg Q3W.

NCT ID: NCT03618433 Completed - Breast Cancer Clinical Trials

KİNECT® - Video Games Based Physiotherapy Programme in Patients With Breast Cancer Surgery

Start date: September 3, 2018
Phase: N/A
Study type: Interventional

The main objective of the study is to investigate the effects of Kinect® video based technology on pain, functionality, muscle strength, fatigue and quality of life in patients with breast cancer surgery and axillary node dissection.

NCT ID: NCT03618017 Completed - Clinical trials for Breast Cancer Female

The ConnectedCancerCare Pilot Study (CCC)

CCC
Start date: August 8, 2018
Phase: N/A
Study type: Interventional

This study is an NCI-funded, randomized control pilot trial to evaluate: (1) the feasibility and acceptability of a web-based, personalized navigation tool (ConnectedCancerCare) and (2) explore whether the tool improves delivery of team-based survivorship care for women who have recently finished primary breast cancer treatment.

NCT ID: NCT03615430 Completed - Breast Cancer Clinical Trials

Serratus Plane Block in Preventing Postoperative Pain of Mastectomy

Start date: August 1, 2018
Phase: N/A
Study type: Interventional

A prospective, double-blinded randomized controlled, 1-year follow-up study was designed to compare the analgesic effect of serratus plane block (SPB) after breast cancer surgery. Women undergoing radical mastectomy were dIvided into Control group and SPB group. The postoperative acute pain was evaluated by numerical rating scale (NRS) and the effect of preventing chronic pain was assessed at 3, 6, 12 months after surgery by NRS.

NCT ID: NCT03612934 Completed - Breast Cancer Clinical Trials

The Impact of SPC on Advanced Breast Cancer Patients

Start date: May 1, 2015
Phase:
Study type: Observational

The aim of this prospective, observational study is the evaluation of the effectiveness of a 14-day Specialist Palliative Care therapy in participants with advanced breast cancer carried out in a stationary palliative care unit in Poland. The length of the entire study will be 36 months.

NCT ID: NCT03612596 Completed - Breast Cancer Clinical Trials

Narrative Visualization for Breast Cancer Survivors' Physical Activity

Start date: September 1, 2018
Phase: N/A
Study type: Interventional

This study tests the feasibility and acceptability of a physical activity intervention that combines use of a wearable activity monitor with a scrapbook. Half of the participants will receive this enhanced intervention, while the other half will receive a wearable activity monitor with a standard step log.

NCT ID: NCT03611543 Completed - Breast Cancer Clinical Trials

Evaluating Image Quality and Comfort of an Investigational Curved Paddle Compared to a Standard Paddle

Start date: October 20, 2016
Phase:
Study type: Observational

The goal of this study is to evaluate patient comfort during compression with a standard flat mammographic paddle and an investigational curved paddle. This is a study that will be performed with x-ray imaging and will be used to determine if an overall reduction in pain can be appreciated in patients without loss in image quality as compared to the current standard mammogram. Another benefit of the curved paddle may be an increase of perceivable and measurable tissue capture.

NCT ID: NCT03609671 Completed - Breast Cancer Clinical Trials

Emotions Immunology and Breast Cancer

Start date: November 23, 2015
Phase: N/A
Study type: Interventional

Pilot study representing a proof of concept regarding the potential for immune system enhancement with psychotherapy, resulting in improved immunological response at lumpectomy or mastectomy in patients undergoing neoadjuvant chemotherapy.